Theracryf PLC Share Price (TCF)

Thank goodness that the final results are due, I bet the board would say nothing to the shareholders about the Stalicla deal progress for another six months otherwise. Don’t expect too much positive news, TCF have not received a single penny of income in the last year apart from the share placing. I can’t believe how the news here has totally dried up. You never hear anything about SFX-01 nowadays.

Why would they not stump up the (according to Evgen BOD now overdue) cash payment, with all the potential risks that such a move might entail, if they were satisfied with our product? If it is that good, they run the risk of someone else snapping it up and leaving them with a lost opportunity?

Why don't you give Stal a call and let us know what they say.

The level of trust most people have in the BOD here now is commensurate with their history, IMO.

Anyway, 8 days for some greater clarity. It would of course be good to hear from the BOD where things stand on Stal before then, but I am not holding my breath. GLA.

Why would Stallicia enter into a contract with a company to acquire the rights to use its primary asset, Sulforaphane, and then not use that product in its own trials?

And yet, not enough interest, it seems, to make the payment that the company feel Stal owes us now. But which the BOD has informed us is being disputed.

Seemingly no other interest from any other party, including big pharma, to enter into a JV, or make an outright offer for, well anything here.

Which is why we are where we are and presumably why several of the main shareholders chose to be diluted, rather than retain their size of position here, after the highly dilutive raise.

The solubility bioavailability and stability of SFX-01 makes it superior to other forms of sulforaphanes .Hence the interest from Stalicla ?

SFX-01, also known as Sulforadex®, is a synthetic form of sulforaphane that is stabilized by an alpha-cyclodextrin ring. The alpha-cyclodextrin (Alfadex) is therapeutically inert and has a lipophilic core which stabilizes the lipophilic sulforaphane1. This makes it overall water-soluble, which greatly enhances the bioavailability and stability of sulforaphane